This article was originally co-published by Stat and ProPublica. It’s a promising new drug for multiple myeloma, one of the most savage blood cancers. Called Ninlaro, it can be taken as a pill, sparing patients painful injections or cumbersome IV treatments. In a video sponsored by the manufacturer, Takeda Pharmaceutical Co., one patient even hailed Ninlaro as “my savior.” The U.S.
Topics: called ninlaro takeda pharmaceutical co the u.s food drug administration dr karen kelly uc davis comprehensive cancer dr kashif ali they re pat conley fayetteville georgia lordy john maraganore biotechnology innovation organization nih national institutes yondelis affordable care act alaska natives hispanics hawaii bristol-myers squibb co sanofi plavix pacific islander puerto rican european american mexican dr jonathan jackson community access recruitment engagement research general hospital boston the national black church initiative commissioner scott gottlieb action plan gloria sanchez-contreras dr rachel sherman sherman when diversity alnylam pharmaceuticals inc european union tokyo australia austria denmark new zealand sweden clinical phil rowlands asked drugmakers income patients laurie halloran maryland hematology criteria general s jackson agriculture though aredia taylor s elroy johnson dr larry anderson texas southwestern medical spurred congress january drug trials snapshot national cancer institute eighteen an fda richard pazdur higher takeda s alunbrig genentech s alecensa meghan cox similarly dr daniel spratt michigan johnson s satu glawe like genentech zytiga sentinel minorities leaving like african it s dr linda burhansstipanov native american cancer research corporation angela marshall black women s health imperative u.s public health service indian health service human services leukemia lymphoma society sarah elizabeth borst thomas goode durham north carolina pulitzer prize-winning propublica it s ninlaro a in i pharmaceutical takeda u.s u.s u.s a americans fda loading kelly center ali oncology the the if african pharmaceutical in i in health black johnson johnson asian native alaska native native inadequate san university california francisco jackson mass black the fda the fda sherman fda s ceo japan u.s rowlands takeda s he aredia taylor u.s department taylor taylor taylor i alecensa genentech we erleada j&j glawe african american native american the marshall health goode percent study work people blood enrollment group cell effects conducted doctor enroll report lung trust cure doesn months costs efforts longer spent product tumors development outcomes member long don test stem meet extend number drove wouldn excluded cost mothers told type noted won showed ensure founder control doctors deputy types spend support helped household reflect wrote respond represented
BING NEWS:
- Coping in the aftermath of a cancer diagnosis
Receiving a cancer diagnosis can be one of the most stressful, pivotal moments in an individual’s life. Fred Hutch social psychologist and health communication researcher, Megan J. Shen, PhD, shares ...
05/2/2024 - 5:13 am | View Link - New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumor
An mRNA cancer vaccine quickly reprogrammed the immune system to attack the most aggressive type of brain tumor in a first-ever human clinical trial.
05/1/2024 - 1:16 pm | View Link - ‘Game-Changing’ Prostate Cancer Screening Trial Could Cut Deaths by 40%
With no current screening programme in the UK, experts believe this £42m project is a ‘pivotal moment’ in the fight against prostate cancer ...
05/1/2024 - 5:02 am | View Link - Thousands of prostate cancer deaths a year could be prevented by 'pivotal' new trial
The £42 million project, known as Transform, has been hailed as "a pivotal moment in the history of prostate cancer research" by experts. It could save up to 5,000 lives a year ...
05/1/2024 - 12:16 am | View Link - Colorectal cancer is increasing among young people. It’s time to boost research on it
Despite its devastating impact, colorectal cancer is the only top-five cancer killer without its own research program within the Department of Defense's Congressionally Directed Medical Research ...
04/30/2024 - 9:30 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more